Defense World
14 Mar 2026, 05:30 UTC · 27w ago
Stoke Therapeutics (NASDAQ:STOK) Trading Down 6.6% After Insider Selling
Verdict
Headline takes no side. We score STOK −0.60 across two claims — strongly bearish.
- Expected · STOK
−0.60strongly bearish
−1 bearish0bullish +1More negative than 78% of ticker scores this week
- Actual





